BostonGene CCO Dr. Ferran Prat to Moderate External Innovation Panel at Longwood Healthcare Leaders Boston CEO Conference
BostonGene, the developer of an AI model for tumor and immune biology, Ferran Prat, PhD, JD, Chief Commercial Officer at BostonGene, will moderate the “Ecosystem of External Innovation” panel at the Longwood Healthcare Leaders Boston CEO conference. The session will focus on global sourcing, pipeline resource allocation, regulatory alignment, and responsible AI integration. Prat will join executive leaders to discuss cross-industry partnerships with biopharma CEOs, heads of research and development, life science investors, and academics. The panel will examine how industry leaders evaluate external scientific assets, navigate cross-border data and regulatory dynamics, and leverage AI to optimize development and outcomes. BostonGene uses its AI model of tumor and immun biology to deliver disease-level insights and enable precision decision-making across oncology and immune-mediated diseases.
gepubliceerd : 9 uur geleden door in Business Health Tech
Dr. Prat to lead session on global sourcing, pipeline resource allocation, regulatory alignment, and responsible AI integration
BostonGene, developer of an AI model for tumor and immune biology, toda... [2195 symbols]
Onderwerpen: Business Leaders
